research The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications 38 citations , June 2015 in “Expert Opinion on Therapeutic Targets” Blocking the prolactin receptor might help treat various diseases, but more research is needed.
research Recent approaches of antibody therapeutics in androgenetic alopecia August 2024 in “Frontiers in Pharmacology” Antibody treatments show promise for hair loss but need more research.
research Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women 3 citations , May 2018 in “Reproductive Sciences” The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.
research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.
research Recent Advances in Drug Development for Hair Loss April 2025 in “International Journal of Molecular Sciences” New treatments for hair loss show promise with advanced therapies and better targeting.